Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4E22

Structure of cytidine monophosphate kinase from Yersinia pseudotuberculosis

4E22 の概要
エントリーDOI10.2210/pdb4e22/pdb
分子名称Cytidylate kinase, SULFATE ION (3 entities in total)
機能のキーワードp-loop, cmp/atp binding, transferase
由来する生物種Yersinia pseudotuberculosis
細胞内の位置Cytoplasm (By similarity): B1JRD8
タンパク質・核酸の鎖数1
化学式量合計27877.74
構造登録者
Clark, E.A.,Acharya, K.R. (登録日: 2012-03-07, 公開日: 2012-12-19, 最終更新日: 2024-02-28)
主引用文献Walker, N.J.,Clark, E.A.,Ford, D.C.,Bullifent, H.L.,McAlister, E.V.,Duffield, M.L.,Acharya, K.R.,Oyston, P.C.
Structure and function of cytidine monophosphate kinase from Yersinia pseudotuberculosis, essential for virulence but not for survival.
Open Biol, 2:120142-120142, 2012
Cited by
PubMed Abstract: The need for new antibiotics has become pressing in light of the emergence of antibiotic-resistant strains of human pathogens. Yersinia pestis, the causative agent of plague, is a public health threat and also an agent of concern in biodefence. It is a recently emerged clonal derivative of the enteric pathogen Yersinia pseudotuberculosis. Previously, we developed a bioinformatic approach to identify proteins that may be suitable targets for antimicrobial therapy and in particular for the treatment of plague. One such target was cytidine monophosphate (CMP) kinase, which is an essential gene in some organisms. Previously, we had thought CMP kinase was essential for Y. pseudotuberculosis, but by modification of the mutagenesis approach, we report here the production and characterization of a Δcmk mutant. The isogenic mutant had a growth defect relative to the parental strain, and was highly attenuated in mice. We have also elucidated the structure of the CMP kinase to 2.32 Å, and identified three key residues in the active site that are essential for activity of the enzyme. These findings will have implications for the development of novel CMP kinase inhibitors for therapeutic use.
PubMed: 23271832
DOI: 10.1098/rsob.120142
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.323 Å)
構造検証レポート
Validation report summary of 4e22
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon